当前位置:首页 >> 代理品牌 >> RELIATech

Receptor Ligand Technologies GmbH公司(RELIA Tech)位于德国不伦瑞克,是一家后基因组生物技术公司,该公司运用独特技术专注于受体和配体的发现与研究,并使之商业化,产品广泛用于科学研究、实验诊断和临床应用。RELIA Tech的灵活性和竞争力必将使其在这个快速整合的功能基因组学和蛋白组学的新时代发展壮大。RELIA公司提供的细胞因子、生长因子、重组蛋白产品均有内毒素检测项目,且内毒素水平非常低。

 

Receptor Ligand Technologies GmbH (RELIATech) is a post-genomic biotechnology company focused on the discovery and commercialisation of novel technologies and products in the field of ligand-receptor interaction for research, diagnostics and for the clinical community. The company located in Braunschweig, Germany, was founded in October 2000 by:

 

Prof. Avner Yayon

Weizmann Institute of Science (WIS), Israel

 

Dr. Herbert A. Weich

German Research Centre for Biotechnology (GBF), Germany

 

Dr. Bernhard Barleon

Clinic for Tumor Biology (KTB), Germany

 

The founders are cell and molecular biologists working in the field of growth factor interaction, tyrosine kinases and their signalling pathways involved in tissue remodelling, homeostasis and disease for more than 1 decade. In particular Dr. Herbert A. Weich and Dr. Bernhard Barleon have worked in basic research in the field of angiogenesis, tumor angiogenesis and the progression of solid tumors.   

 

Signal proteins such as "growth factors and cytokines", together with their transmembrane / "soluble receptors" and associated kinases, are critically involved in the development and function of all higher organisms as key regulatory molecules in physiological and pathophysioloical conditions. These polypeptides regulate cell differentiation, tissue remodelling and homeostasis, and are deregulated in various disease states. The discovery of new growth-regulating genes by the human genome project coding for novel signaling proteins, together with the elucidation of their function, will no doubt be one of the major challenges in the next decade.

 

RELIATech’s mission is the development and commercialisation of new products useful in the field of "receptor and ligand interaction" for basic research, drug development and for the clinical community. RELIATech’s flexibility and competence will definitely enable its rapid integration and expansion in this new era of functional genomics and proteomics.

版权所有 2004-2011 上海博晗生物科技有限公司
欢迎拨打服务热线: 021-54253791,64693763 邮箱: order@biosun.cn
沪ICP备10213400号-1